Compare Hewlett Packard Enterprise Co (HPE) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hewlett Packard Enterprise Co vs Novartis AG — how do they compare? Hewlett Packard Enterprise Co trades at $55.46 (market cap $72.01B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 4.1× Hewlett Packard Enterprise Co's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| HPE | NVS | |
|---|---|---|
Market Cap | $72.01B | $295.37B |
Sector | Technology | Health |
52-Week High | $56.14 | $168.62 |
52-Week Low | $20.01 | $119.31 |
Enterprise Value | $87.96B | $336.69B |
Dividend Yield | 1.05% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
